Clinical Trial Update: Xpert MTB/Rif, a New Tool for the Diagnosis of Pulmonary Tuberculosis in Two Municipalities in Brazil [Phase 4]

View source ↗

Summary

Phase 4 study updating the use of Xpert MTB/RIF for diagnosing pulmonary tuberculosis in two municipalities in Brazil. Results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis
• Tuberculosis

Drugs mentioned

• Xpert MTB/RIF

Snippet

Sponsor: Ataulpho de Paiva Foundation | Conditions: Tuberculosis | Phase 4 | Status: COMPLETED | Results posted: 2014-03-12